Home › Acute Lymphoblastic Leukemia › District of Columbia › Washington
Acute Lymphoblastic Leukemia clinical trials in Washington, DC
16 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Recruiting
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 2
- Children's National Hospital, Washington D.C.
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Children's National Medical Center, Washington D.C.
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's National Medical Center, Washington D.C.
- Nih/Niaid, Bethesda · 7 mi away
- Nih/Nhlbi, Bethesda · 7 mi away
Massage Impact on Sleep in Pediatric Oncology
Recruiting
- Children's National Hospital, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Feasibility/Acceptability of Attentional-Control Training in Survivors
Recruiting
- Children's National Hospital, Washington D.C.
Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
Recruiting
- Children's National Hospital, Washington D.C.
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's National Medical Center, Washington D.C.
- National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7 mi away
Acute Lymphoblastic Leukemia trials in other cities
- Houston, TX28 studies
- New York City, NY24 studies
- Baldwin Park, CA21 studies
- Seattle, WA21 studies
- Atlanta, GA19 studies
- Chicago, IL19 studies
- Memphis, TN16 studies
- Philadelphia, PA16 studies
- Boston, MA15 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
- Mountain View, CA13 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease29 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.